| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 16 | 2024 | 883 | 4.080 |
Why?
|
| Laryngeal Neoplasms | 6 | 2016 | 85 | 2.520 |
Why?
|
| Biomarkers, Tumor | 12 | 2025 | 1580 | 2.450 |
Why?
|
| Prostatic Neoplasms | 15 | 2020 | 1406 | 2.080 |
Why?
|
| Neoplastic Stem Cells | 6 | 2016 | 329 | 1.640 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2015 | 747 | 1.470 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2020 | 1265 | 1.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2017 | 2008 | 0.940 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2025 | 53 | 0.850 |
Why?
|
| RNA, Untranslated | 1 | 2025 | 109 | 0.840 |
Why?
|
| Chordoma | 3 | 2013 | 18 | 0.830 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2015 | 194 | 0.820 |
Why?
|
| Gene Expression Profiling | 11 | 2024 | 1800 | 0.810 |
Why?
|
| Mutation | 6 | 2019 | 6064 | 0.800 |
Why?
|
| Alternative Splicing | 2 | 2019 | 310 | 0.700 |
Why?
|
| Mutation, Missense | 3 | 2015 | 919 | 0.670 |
Why?
|
| SOXB1 Transcription Factors | 3 | 2015 | 57 | 0.650 |
Why?
|
| Transfection | 5 | 2015 | 961 | 0.600 |
Why?
|
| rab3 GTP-Binding Proteins | 1 | 2019 | 7 | 0.590 |
Why?
|
| Optic Atrophy | 1 | 2019 | 42 | 0.570 |
Why?
|
| Abnormalities, Multiple | 4 | 2019 | 964 | 0.540 |
Why?
|
| Cataract | 1 | 2019 | 153 | 0.520 |
Why?
|
| Skin Abnormalities | 2 | 2014 | 34 | 0.510 |
Why?
|
| Microcephaly | 3 | 2019 | 346 | 0.510 |
Why?
|
| Machine Learning | 1 | 2020 | 380 | 0.480 |
Why?
|
| CHARGE Syndrome | 1 | 2015 | 7 | 0.470 |
Why?
|
| Prostate | 2 | 2017 | 402 | 0.460 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 30 | 0.460 |
Why?
|
| Centrioles | 1 | 2015 | 5 | 0.460 |
Why?
|
| Male | 36 | 2024 | 64385 | 0.460 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 91 | 0.450 |
Why?
|
| Neoplasms | 2 | 2025 | 2975 | 0.450 |
Why?
|
| White Coat Hypertension | 1 | 2015 | 10 | 0.450 |
Why?
|
| Usher Syndromes | 1 | 2015 | 11 | 0.440 |
Why?
|
| Cell Proliferation | 5 | 2015 | 2462 | 0.440 |
Why?
|
| Saliva | 1 | 2015 | 124 | 0.440 |
Why?
|
| Hypogonadism | 1 | 2019 | 295 | 0.440 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2014 | 2 | 0.430 |
Why?
|
| Decision Making | 1 | 2020 | 712 | 0.430 |
Why?
|
| Dwarfism | 1 | 2015 | 101 | 0.430 |
Why?
|
| Humans | 48 | 2025 | 130080 | 0.420 |
Why?
|
| Cornea | 1 | 2019 | 565 | 0.420 |
Why?
|
| Up-Regulation | 5 | 2015 | 823 | 0.420 |
Why?
|
| DNA Helicases | 1 | 2015 | 234 | 0.410 |
Why?
|
| Prognosis | 6 | 2025 | 4848 | 0.410 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2018 | 992 | 0.400 |
Why?
|
| Ephrin-B1 | 1 | 2013 | 9 | 0.400 |
Why?
|
| Foot Deformities | 1 | 2013 | 4 | 0.400 |
Why?
|
| Real-Time Polymerase Chain Reaction | 5 | 2020 | 525 | 0.390 |
Why?
|
| Down-Regulation | 5 | 2015 | 646 | 0.390 |
Why?
|
| Tyrosinemias | 1 | 2013 | 7 | 0.390 |
Why?
|
| Middle Aged | 17 | 2024 | 28314 | 0.390 |
Why?
|
| Skull Base Neoplasms | 1 | 2013 | 39 | 0.380 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2012 | 13 | 0.380 |
Why?
|
| Neutropenia | 1 | 2014 | 209 | 0.370 |
Why?
|
| Cochlea | 1 | 2013 | 86 | 0.370 |
Why?
|
| Lymph Nodes | 1 | 2014 | 356 | 0.360 |
Why?
|
| ROC Curve | 4 | 2020 | 609 | 0.360 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2012 | 107 | 0.350 |
Why?
|
| Case-Control Studies | 6 | 2024 | 3349 | 0.350 |
Why?
|
| Limb Deformities, Congenital | 1 | 2013 | 115 | 0.350 |
Why?
|
| Intellectual Disability | 1 | 2019 | 1086 | 0.350 |
Why?
|
| Lymphocytes | 1 | 2013 | 345 | 0.350 |
Why?
|
| Craniofacial Abnormalities | 1 | 2013 | 251 | 0.340 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 156 | 0.340 |
Why?
|
| Tumor Cells, Cultured | 4 | 2016 | 975 | 0.330 |
Why?
|
| Proteins | 2 | 2015 | 1004 | 0.330 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 679 | 0.330 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 1690 | 0.300 |
Why?
|
| Phenotype | 5 | 2019 | 4452 | 0.300 |
Why?
|
| Pedigree | 4 | 2019 | 1669 | 0.290 |
Why?
|
| Female | 24 | 2024 | 70246 | 0.290 |
Why?
|
| Prostatectomy | 3 | 2020 | 304 | 0.280 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 635 | 0.280 |
Why?
|
| Prenatal Diagnosis | 1 | 2012 | 611 | 0.270 |
Why?
|
| Cell Cycle Proteins | 3 | 2015 | 705 | 0.270 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 1931 | 0.260 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2004 | 47 | 0.250 |
Why?
|
| Adult | 13 | 2024 | 31011 | 0.250 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2004 | 57 | 0.250 |
Why?
|
| Cell Line, Tumor | 7 | 2015 | 3714 | 0.240 |
Why?
|
| Bone Neoplasms | 1 | 2011 | 470 | 0.240 |
Why?
|
| Turkey | 2 | 2019 | 66 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1205 | 0.240 |
Why?
|
| cdc25 Phosphatases | 1 | 2005 | 19 | 0.230 |
Why?
|
| AC133 Antigen | 2 | 2016 | 34 | 0.230 |
Why?
|
| Liquid Biopsy | 1 | 2025 | 15 | 0.220 |
Why?
|
| Genetic Therapy | 2 | 2014 | 711 | 0.220 |
Why?
|
| Apoptosis | 5 | 2015 | 1826 | 0.220 |
Why?
|
| Aged | 8 | 2015 | 20821 | 0.210 |
Why?
|
| Electroconvulsive Therapy | 1 | 2024 | 79 | 0.200 |
Why?
|
| Genes, Dominant | 1 | 2004 | 242 | 0.200 |
Why?
|
| RNA, Long Noncoding | 1 | 2025 | 219 | 0.180 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1800 | 0.170 |
Why?
|
| Adenoviridae | 1 | 2004 | 581 | 0.170 |
Why?
|
| Schizophrenia | 1 | 2024 | 323 | 0.170 |
Why?
|
| Tissue Kallikreins | 1 | 2020 | 7 | 0.170 |
Why?
|
| Normal Distribution | 1 | 2020 | 19 | 0.160 |
Why?
|
| Exome | 2 | 2015 | 1061 | 0.160 |
Why?
|
| Probability | 1 | 2020 | 305 | 0.150 |
Why?
|
| Genes, p53 | 1 | 2020 | 208 | 0.150 |
Why?
|
| Infant | 8 | 2016 | 13269 | 0.150 |
Why?
|
| Disease Progression | 3 | 2015 | 2191 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2015 | 1014 | 0.140 |
Why?
|
| INDEL Mutation | 1 | 2019 | 93 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 248 | 0.140 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 125 | 0.140 |
Why?
|
| Child | 8 | 2019 | 26173 | 0.140 |
Why?
|
| Child, Preschool | 7 | 2016 | 15005 | 0.140 |
Why?
|
| Siblings | 1 | 2019 | 201 | 0.130 |
Why?
|
| Area Under Curve | 2 | 2015 | 303 | 0.130 |
Why?
|
| Homozygote | 1 | 2019 | 533 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 2322 | 0.120 |
Why?
|
| DNA Damage | 1 | 2020 | 509 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1374 | 0.120 |
Why?
|
| Melanoma | 1 | 2004 | 927 | 0.120 |
Why?
|
| Receptors, Oxytocin | 1 | 2016 | 20 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2004 | 903 | 0.120 |
Why?
|
| Serum Globulins | 1 | 2015 | 7 | 0.120 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2015 | 1 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 719 | 0.120 |
Why?
|
| Heterozygote | 2 | 2015 | 721 | 0.120 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 41 | 0.120 |
Why?
|
| Phorbols | 1 | 2015 | 5 | 0.120 |
Why?
|
| Platelet Count | 1 | 2015 | 139 | 0.110 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 60 | 0.110 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2015 | 99 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 83 | 0.110 |
Why?
|
| G1 Phase | 1 | 2015 | 68 | 0.110 |
Why?
|
| Preoperative Period | 1 | 2015 | 89 | 0.110 |
Why?
|
| RNA Interference | 1 | 2016 | 491 | 0.110 |
Why?
|
| De Lange Syndrome | 1 | 2015 | 44 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2891 | 0.110 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 38 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2015 | 223 | 0.110 |
Why?
|
| Hepatitis B, Chronic | 1 | 2015 | 84 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 1208 | 0.110 |
Why?
|
| Cell Differentiation | 4 | 2011 | 1906 | 0.110 |
Why?
|
| Retinitis Pigmentosa | 1 | 2015 | 77 | 0.110 |
Why?
|
| Gold | 1 | 2014 | 54 | 0.100 |
Why?
|
| Phosphotransferases | 1 | 2014 | 33 | 0.100 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 208 | 0.100 |
Why?
|
| Metal Nanoparticles | 1 | 2014 | 53 | 0.100 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 138 | 0.100 |
Why?
|
| Cell Movement | 2 | 2015 | 873 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2015 | 330 | 0.100 |
Why?
|
| HeLa Cells | 1 | 2015 | 689 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2015 | 849 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 259 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 254 | 0.100 |
Why?
|
| RNA, Transfer | 1 | 2014 | 57 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2013 | 2548 | 0.100 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 204 | 0.100 |
Why?
|
| Hyaluronan Receptors | 1 | 2014 | 64 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 110 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 777 | 0.100 |
Why?
|
| Prostatic Hyperplasia | 1 | 2014 | 108 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 6765 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 222 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 98 | 0.100 |
Why?
|
| Oncogenes | 1 | 2014 | 163 | 0.100 |
Why?
|
| Cutis Laxa | 1 | 2013 | 10 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 197 | 0.100 |
Why?
|
| Cell Separation | 1 | 2014 | 220 | 0.100 |
Why?
|
| Algorithms | 1 | 2020 | 1662 | 0.100 |
Why?
|
| Exons | 1 | 2015 | 759 | 0.100 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 425 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 373 | 0.100 |
Why?
|
| Karyotype | 1 | 2013 | 30 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 128 | 0.100 |
Why?
|
| Hearing Loss | 1 | 2015 | 203 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1592 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 1278 | 0.090 |
Why?
|
| Ichthyosis | 1 | 2012 | 31 | 0.090 |
Why?
|
| Hashimoto Disease | 1 | 2013 | 31 | 0.090 |
Why?
|
| Dermatitis | 1 | 2012 | 27 | 0.090 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 118 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 573 | 0.090 |
Why?
|
| Hamartoma | 1 | 2013 | 51 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 631 | 0.090 |
Why?
|
| Skin | 1 | 2015 | 538 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 902 | 0.090 |
Why?
|
| Stem Cells | 2 | 2007 | 703 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2013 | 413 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2018 | 5034 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2014 | 409 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2392 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2014 | 344 | 0.090 |
Why?
|
| Imatinib Mesylate | 1 | 2011 | 47 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1453 | 0.090 |
Why?
|
| Base Sequence | 1 | 2015 | 2729 | 0.090 |
Why?
|
| Immunoglobulin E | 1 | 2012 | 215 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 392 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2014 | 299 | 0.090 |
Why?
|
| Vidarabine | 1 | 2011 | 91 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 713 | 0.090 |
Why?
|
| Etoposide | 1 | 2011 | 111 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 404 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2015 | 1439 | 0.090 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2012 | 66 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2011 | 100 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3464 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2013 | 765 | 0.080 |
Why?
|
| Benzamides | 1 | 2011 | 125 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2014 | 1481 | 0.080 |
Why?
|
| Vincristine | 1 | 2011 | 188 | 0.080 |
Why?
|
| Genome-Wide Association Study | 2 | 2015 | 1827 | 0.080 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 449 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2011 | 122 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2013 | 205 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 236 | 0.080 |
Why?
|
| Peptides | 1 | 2014 | 704 | 0.080 |
Why?
|
| Recurrence | 1 | 2014 | 1475 | 0.080 |
Why?
|
| Doxorubicin | 1 | 2011 | 289 | 0.080 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 416 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 351 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2020 | 4645 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2885 | 0.080 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 194 | 0.080 |
Why?
|
| Cisplatin | 1 | 2011 | 274 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2016 | 1075 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2011 | 340 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 460 | 0.080 |
Why?
|
| Piperazines | 1 | 2011 | 267 | 0.080 |
Why?
|
| Cell Survival | 3 | 2012 | 828 | 0.080 |
Why?
|
| Family | 1 | 2012 | 587 | 0.070 |
Why?
|
| Methotrexate | 1 | 2011 | 348 | 0.070 |
Why?
|
| Ki-67 Antigen | 2 | 2006 | 100 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 755 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2015 | 1543 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1874 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 901 | 0.070 |
Why?
|
| Genotype | 1 | 2014 | 2588 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2011 | 454 | 0.070 |
Why?
|
| Computational Biology | 1 | 2013 | 859 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 1208 | 0.070 |
Why?
|
| Transcriptome | 1 | 2015 | 1097 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2014 | 2825 | 0.060 |
Why?
|
| Cartilage | 1 | 2007 | 52 | 0.060 |
Why?
|
| Adipocytes, Brown | 1 | 2007 | 27 | 0.060 |
Why?
|
| Chondrogenesis | 1 | 2007 | 31 | 0.060 |
Why?
|
| Somatomedins | 1 | 2006 | 33 | 0.060 |
Why?
|
| Chondrocytes | 1 | 2007 | 48 | 0.060 |
Why?
|
| Ossification, Heterotopic | 1 | 2007 | 36 | 0.060 |
Why?
|
| Neurites | 1 | 2006 | 43 | 0.060 |
Why?
|
| Ganglia, Spinal | 1 | 2006 | 65 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 815 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 1 | 2006 | 110 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2007 | 181 | 0.060 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 226 | 0.060 |
Why?
|
| Cell Division | 2 | 2004 | 718 | 0.060 |
Why?
|
| Monocytes | 1 | 2007 | 335 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2015 | 8554 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2005 | 212 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2014 | 2399 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 2597 | 0.050 |
Why?
|
| G2 Phase | 1 | 2004 | 39 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 480 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 82 | 0.050 |
Why?
|
| Oxygen | 1 | 2007 | 549 | 0.050 |
Why?
|
| CDC2 Protein Kinase | 1 | 2004 | 36 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2003 | 43 | 0.050 |
Why?
|
| Cyclins | 1 | 2004 | 93 | 0.050 |
Why?
|
| Brain | 1 | 2015 | 3145 | 0.050 |
Why?
|
| Animals | 8 | 2014 | 33656 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 88 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2006 | 695 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 145 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 980 | 0.040 |
Why?
|
| Pregnancy | 1 | 2012 | 7390 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 282 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2015 | 17541 | 0.040 |
Why?
|
| Time Factors | 2 | 2006 | 6165 | 0.040 |
Why?
|
| Mice | 7 | 2014 | 18161 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 3404 | 0.030 |
Why?
|
| Mice, Inbred NOD | 2 | 2007 | 298 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 968 | 0.030 |
Why?
|
| Globulins | 1 | 2015 | 4 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2007 | 583 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2015 | 111 | 0.030 |
Why?
|
| Exonucleases | 1 | 2015 | 27 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 30 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2014 | 27 | 0.030 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 81 | 0.030 |
Why?
|
| Cerebrum | 1 | 2014 | 32 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 130 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 166 | 0.030 |
Why?
|
| Endoribonucleases | 1 | 2014 | 87 | 0.020 |
Why?
|
| Hypertelorism | 1 | 2013 | 12 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 209 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2015 | 502 | 0.020 |
Why?
|
| Syndrome | 1 | 2015 | 1156 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 292 | 0.020 |
Why?
|
| Corpus Callosum | 1 | 2013 | 105 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2007 | 4691 | 0.020 |
Why?
|
| Biopsy | 1 | 2015 | 1240 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 818 | 0.020 |
Why?
|
| Adolescent | 3 | 2015 | 20801 | 0.020 |
Why?
|
| Craniosynostoses | 1 | 2013 | 146 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2015 | 756 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 533 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 9981 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 588 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1783 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2007 | 117 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2009 | 316 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2009 | 435 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2006 | 3810 | 0.020 |
Why?
|
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 1 | 2006 | 5 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2006 | 13 | 0.020 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2006 | 34 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 85 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2007 | 112 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2007 | 86 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 120 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2006 | 72 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2006 | 229 | 0.010 |
Why?
|
| Biomarkers | 1 | 2015 | 3358 | 0.010 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 127 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 152 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2006 | 257 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2007 | 4639 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2006 | 448 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 449 | 0.010 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2003 | 13 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 583 | 0.010 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2003 | 37 | 0.010 |
Why?
|
| Osteopontin | 1 | 2003 | 54 | 0.010 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2003 | 68 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 358 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2003 | 229 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 2554 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 576 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 1363 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 324 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 735 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 1570 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 1674 | 0.010 |
Why?
|